CLINICAL PHARMACOKINETICS OF REMOXIPRIDE - A NEW POTENTIAL ANTIPSYCHOTIC COMPOUND

被引：0
|
作者：
NILSSON, MI [1 ]
VONBAHR, C [1 ]
机构：
[1] ASTRA LAKEMEDEL AB,CLIN RES,CLIN PHARMACOL,S-15185 SODERTALJE,SWEDEN
来源：
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE | 1986年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A21 / A21
页数：1
相关论文
共 50 条
  • [41] CHEMISTRY OF NEW DERIVATIVES OF TROPANE ALKALOIDS AND PHARMACOKINETICS OF A NEW QUATERNARY COMPOUND
    DECKERS, W
    POSTGRADUATE MEDICAL JOURNAL, 1975, 51 : 76 - 81
  • [42] Investigation into the antinociceptive potential of remoxipride administered intrathecally in sheep
    Main, DCJ
    Waterman, AE
    Kilpatrick, IC
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 524 - 530
  • [43] New potential atypical antipsychotic with unusual pharmacological profile
    Laszlovszky, I
    Kiss, B
    Csejtei, M
    Lapis, E
    Kalman, E
    Szabo, S
    Paroczai, M
    Acs, T
    Domany, G
    Karpati, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) : 124 - 124
  • [44] PSYCHOPHARMACOLOGICAL PROFILE OF DAPIPRAZOLE, A NEW POTENTIAL ANTIPSYCHOTIC AGENT
    SILVESTRINI, B
    LISCIANI, R
    BALDINI, A
    DESANCTIS, AJ
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1982, 32-1 (06): : 668 - 673
  • [45] Org 23366: A potential new atypical antipsychotic.
    Gibson, SG
    Connick, J
    Jaap, D
    McGuire, R
    Rae, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U950 - U950
  • [46] The effect of the antipsychotic drug remoxipride on memory; a preclinical study utilizing the novel object recognition task
    Gonzales, C. Bengtsson
    Ramstrom, A.
    van Doeselaar, L.
    Ogren, S. O.
    Konradsson-Geuken, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S40 - S41
  • [47] Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections
    Yip, Christopher
    Okada, Naomi C.
    Howerton, Amber
    Amei, Amei
    Abel-Santos, Ernesto
    BIOCHEMICAL PHARMACOLOGY, 2021, 183
  • [48] PHARMACOKINETICS OF REMOXIPRIDE CONTROLLED RELEASE AND IMMEDIATE RELEASE CAPSULES IN SCHIZOPHRENIC-PATIENTS
    WIDERLOV, E
    FRANZEN, G
    JANSSON, P
    MOVIN, G
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1990, 5 (02) : 125 - 134
  • [49] BUSPIRONE HYDROCHLORIDE - A UNIQUE NEW ANXIOLYTIC AGENT - PHARMACOKINETICS, CLINICAL-PHARMACOLOGY, ABUSE POTENTIAL AND CLINICAL EFFICACY
    GOLDBERG, HL
    PHARMACOTHERAPY, 1984, 4 (06): : 315 - 324
  • [50] COMPARISON OF THE EFFECTS OF THE NOVEL ANTIPSYCHOTIC AGENT REMOXIPRIDE ON DOPAMINE AND NORADRENALINE TURNOVER IN THE RAT-BRAIN
    MAGNUSSON, O
    FOWLER, CJ
    PHARMACOLOGY & TOXICOLOGY, 1989, 65 (04): : 295 - 298
12345